Vnitr Lek 2018, 64(4):384-393 | DOI: 10.36290/vnl.2018.057

Drug and herbal hepatotoxicity: an overview of clinical classifications

Mária Szántová*, Jozef Sedlačko, Martina Jakabovičová
III. interná klinika LF UK a UNB, Nemocnica akademika Ladislava Dérera, Bratislava

Drug induced liver injury (DILI) is often underdiagnosed disease with increasing incidence. In developed countries it belongs to the leading causes of acute liver failure. Risk groups are women and persons older than 60 years. The work summarizes the up to date information on diagnosis and mostly used classifications on DILI. It is quite often and serious complication of medicament therapy. DILI belongs to the most often cause of acute hepatic failure in the old age in developed countries. Diagnostic procedure includes medical history (time correlation with drug intake), clinical symptoms and blood tests. Laboratory tests may be helpful to specify immunopathogenetic origin, but negative results does not exclude diagnosis. The exclusion of other possible etiological factors is the crucial condition of diagnosis statement.

Keywords: DILI, drug induced liver toxicity; DILIn network; RUCAM classification

Received: August 24, 2017; Accepted: January 30, 2018; Published: April 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Szántová M, Sedlačko J, Jakabovičová M. Drug and herbal hepatotoxicity: an overview of clinical classifications. Vnitr Lek. 2018;64(4):384-393. doi: 10.36290/vnl.2018.057.
Download citation

References

  1. Devarbhavi H. An update on drug-induced liver injury. J Clin Exp Hepatol 2012; 2(3): 247-259. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jceh.2012.05.002>. Go to original source... Go to PubMed...
  2. Kullak-Ublick GA, Andrade RJ, Merz M at al. Drug-induced Liver Injury: Recent Advances in Diagnosis and Risk Assessment. Gut 2017; 66(6): 1154-1164. Dostupné z DOI: <http://dx.doi.org/10.1136/gutjnl-2016-313369>. Go to original source... Go to PubMed...
  3. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46(11): 1331-1336. Go to original source... Go to PubMed...
  4. Fontana RJ, Seef LB, Andrade RJ et al. Standardization of nomenclature and causality in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010; 52(2): 730-742. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.23696>. Go to original source... Go to PubMed...
  5. Garcia-Gortez M, Robles-Diaz M, Orteg-Alonso A et al. Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics. Int J Mol Sci 2016; 17(4): 537. Dostupné z DOI: <http://dx.doi.org/103390/ijmsl7040537>. Go to original source... Go to PubMed...
  6. Suk KT, Kim DJ. Drug-induced liver injury: present and future. Clin Mol Hepatol 2012; 18(3): 249-257. Dostupné z DOI: <http://dx.doi.org/10.3350/cmh.2012.18.3.249>. Go to original source... Go to PubMed...
  7. Bates DW, Cullen DJ, Laird N et al. [ADE Prevention Study Group]. Incidence of adverse drug events and potential adverse drug events. Implication for prevention. JAMA 1995; 274(1): 29-34. Go to original source...
  8. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a metaanalysis of prospective studies. JAMA 1998; 279(15): 1200-1205. Go to original source... Go to PubMed...
  9. Egan LJ. Mechanisms of Drug Toxicity or Intolerance. Dig Dis 2011; 29(2): 172-176. Dostupné z DOI: <http://dx.doi.org/10.1159/000323881>. Go to original source... Go to PubMed...
  10. Shiano TD, Black M. Drug Induced and Toxic Liver Disease. In: Lawrence S, Friedman LS, Keefe EB. Handbook of liver diseases. 3rd ed. Saunders 2011. ISBN 978-1437717259.
  11. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 2004; 38(Suppl 2): S44-S48. Go to original source... Go to PubMed...
  12. Chalasani N, Hayashi PH, Bonkovsky HL et al. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol 2014; 109(7): 950-966. Dostupné z DOI: <http://dx.doi.org/10.1038/ajg.2014.131>. Go to original source... Go to PubMed...
  13. Andrade RJ, Robles M, Ulzurrun E et al. Drug-induced liver injury: insights from genetic studies. Pharmacogenomics 2009; 10(9): 1467-1487. Dostupné z DOI: <http://dx.doi.org/10.2217/pgs.09.111>. Go to original source... Go to PubMed...
  14. Aithal GP, Grove JI. Genome-wide association studies in drug-induced liver injury: step change in understanding the pathogenesis. Semin Liv Dis 2015; 35(4): 421-431. Dostupné z DOI: <http://dx.doi.org/10.1055/s-0035-1567829>. Go to original source... Go to PubMed...
  15. Andrade RJ, Robles M, Fernandez-Castaner A et al. Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists. World J Gastroenterol 2007; 13(3): 329-340. Go to original source... Go to PubMed...
  16. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-245. Go to original source... Go to PubMed...
  17. Garcia-Cortes M, Lucena MI, Pachkoria K et al. Liv SGSD-I. Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 2008; 27(9): 780-789. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2036.2008.03655.x>. Go to original source... Go to PubMed...
  18. Hayashi PH. Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States. Int J Mol Sci 2016; 17(2): 201. Dostupné z DOI: <http://dx.doi.org/10.3390/ijms17020201>. Go to original source... Go to PubMed...
  19. Shapiro MA, Lewis JH. Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin Liver Dis 2007; 11(3): 477-505. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cld.2007.06.003>. Go to original source... Go to PubMed...
  20. Lucena MI, Andrade RJ, Kaplowitz N et al. Phenotypic Characterization of Idiosyncratic Drug-Induced Liver Injury: The Influence of Age and Sex. Hepatology 2009; 49(6): 2001-2009. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.22895>. Go to original source... Go to PubMed...
  21. Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci 2016; 17(1). pii: E14. Dostupné z DOI: <http://dx.doi.org/10.3390/ijms17010014>. Go to original source... Go to PubMed...
  22. Maria VAJ, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26(3): 664-669. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.510260319>. Go to original source... Go to PubMed...
  23. Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol 2000; 33(6): 949-952. Go to original source... Go to PubMed...
  24. Takikawa H, Takamori Y, Kumagi T et al. Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting. Hepatol Res 2003; 27(3): 192-195. Go to original source... Go to PubMed...
  25. Watanabe M, Shibuya A. Validity study of a new diagnostic scale for drug induced liver injury in Japan-comparison with two previous scales. Hepatol Res 2004; 30(3): 148-154. Dostupné z DOI: <http://dx.doi.org/10.1016/j.hepres.2004.08.005>. Go to original source... Go to PubMed...
  26. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46(1): 1323-1330. Go to original source... Go to PubMed...
  27. Norris W, Paredes AH, Lewis JH. Drug-induced liver injury in 2007. Curr Opin Gastroenterol 2008; 24(3): 287-297. Dostupné z DOI: <http://dx.doi.org/10.1097/MOG.0b013e3282f9764b>. Go to original source... Go to PubMed...
  28. Temple R. Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf 2006; 15(4): 241-243. Dostupné z DOI: <http://dx.doi.org/10.1002/pds.1211>. Go to original source... Go to PubMed...
  29. Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of new-onset jaundice: How often is it caused by idiosyncratic drug-induced liver injury in the united states ? Am J Gastroenterol 2007; 102(3): 558-562. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1572-0241.2006.01019.x>. Go to original source... Go to PubMed...
  30. Štátny ústav pre kontrolu liečiv. Dostupné z WWW: <https://www.sukl.sk>.
  31. Státní ústav pro kontrolu léčiv. Dostupné z WWW: <https://www.sukl.cz>.
  32. U.S. Food and drug administration. Dostupné z WWW: <https://www.fda.gov>.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.